Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\28881850
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Oncotarget
2017 ; 8
(32
): 53780-53790
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Transforming growth factor ?: A potential biomarker and therapeutic target of
ventricular remodeling
#MMPMID28881850
Ma Y
; Zou H
; Zhu XX
; Pang J
; Xu Q
; Jin QY
; Ding YH
; Zhou B
; Huang DS
Oncotarget
2017[Aug]; 8
(32
): 53780-53790
PMID28881850
show ga
Transforming growth factor ? (TGF-?) is a multifunctional cytokine that is
synthesized by many types of cells and regulates the cell cycle. Increasing
evidence has led to TGF-? receiving increased and deserved attention in recent
years because it may play a potentially novel and critical role in the
development and progression of myocardial fibrosis and the subsequent progress of
ventricular remodeling (VR). Numerous studies have highlighted a crucial role of
TGF-? in VR and suggest potential therapeutic targets of the TGF-? signaling
pathways for VR. Changes in TGF-? activity may elicit anti-VR activity and may
serve as a novel therapeutic target for VR therapy. This review we discusses the
smad-dependent signaling pathway, such as TGF-?/Smads, TGF-?/Sirtuins, TGF-?/BMP,
TGF-?/miRNAs, TGF-?/MAPK, and Smad-independent signaling pathway of TGF-?, such
as TGF-?/PI3K/Akt, TGF-?/Rho/ROCK,TGF-?/Wnt/?-catenin in the cardiac fibrosis and
subsequent progression of VR. Furthermore, agonists and antagonists of TGF-? as
potential therapeutic targets in VR are also described.